Table 1: Patient demographics and clinical characteristics.

Neoadjuvant chemotherapy value
No 
(%)
Yes 
(%)

Gender 0.87
 Male 70 (76%)66 (76%)
 Female 21 (24%)21 (24%)
Age 0.02
 <60 21 (23%)32 (37%)
 60–6933 (36%)35 (40%)
 >7037 (41%)20 (23%)
Race0.99
 Caucasian 79 (89%)75 (88%)
 Other 10 (11%)10 (12%)
Complete TURBT0.28
 Yes32 (35%)39 (46%)
 No53 (58%)43 (51%)
 Unknown6 (7%)3 (4%)
Cardiac disease0.13
 Yes23 (25%)14 (16%)
 No68 (75%)73 (84%)
Creatinine 0.49
 ≤1.047 (53%)51 (59%)
 >1.041 (47%)36 (41%)